Supernus Pharmaceuticals
SUPN
SUPN
235 hedge funds and large institutions have $1.22B invested in Supernus Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 80 increasing their positions, 87 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
8% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 87
3% less funds holding
Funds holding: 243 → 235 (-8)
11% less capital invested
Capital invested by funds: $1.37B → $1.22B (-$150M)
Holders
235
Holding in Top 10
1
Calls
$8.4M
Puts
$7.54M
Top Buyers
| 1 | +$40.6M | |
| 2 | +$17.3M | |
| 3 | +$16.4M | |
| 4 |
First Manhattan
New York
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$10.5M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$15.1M | |
| 3 | -$15.1M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$11.4M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$10.9M |